Meridian Bioscience Supports Diagnostic Companies in Fighting Coronavirus Pandemic by Providing Zero Cost Proprietary Technology for Evaluation
March 16, 2020 11:51 ET
|
Meridian Bioscience Inc.
CINCINNATI, March 16, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) announced today its increased commitment to the global fight against COVID-19 by making available zero cost...
Meridian Bioscience Announces FDA-Clearance for New Curian™ Analyzer and the Curian™ HpSA® Assay
March 16, 2020 08:00 ET
|
Meridian Bioscience Inc.
CINCINNATI, March 16, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) a provider of immunoassay, molecular, and blood chemistry diagnostic testing solutions, today announced that...
Meridian’s Novel Air-Dryable qPCR Mix Decreases Costs and Simplifies Workflows for Molecular Test Manufacturers
February 26, 2020 08:00 ET
|
Meridian Bioscience Inc.
CINCINNATI, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), following the extremely successful launch of the Lyo-Ready qPCR mixes, is proud to introduce today its...
Meridian Bioscience Signs Definitive Agreement to Acquire Exalenz Bioscience; Adds State-Of-The-Art Urea Breath Test Diagnostics Platform
February 19, 2020 09:15 ET
|
Meridian Bioscience Inc.; Exalenz Bioscience
CINCINNATI and MODIIN, Israel, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) and Exalenz Bioscience Ltd. (TASE: EXEN) announced today that the two companies have entered...
Meridian Bioscience Reports First Quarter Fiscal 2020 Operating Results and Reaffirms 2020 Guidance
February 07, 2020 07:30 ET
|
Meridian Bioscience Inc.
CINCINNATI, Feb. 07, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the first quarter ended December 31, 2019. First Quarter Fiscal 2020...
Meridian Bioscience Lyo-Ready 1-Step RT-qPCR Mix is Used in the Development of Molecular Diagnostics for New Coronavirus Outbreak
January 27, 2020 09:17 ET
|
Meridian Bioscience Inc.
CINCINNATI, Jan. 27, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced a novel coronavirus, identified by Chinese authorities on January 7 and currently named...
Meridian lança nova polimerase de alta fidelidade para oferecer amplificação robusta para aplicações NGS e PCR
January 23, 2020 16:46 ET
|
Meridian Bioscience Inc.
CINCINNATI, Jan. 23, 2020 (GLOBE NEWSWIRE) -- A Meridian Bioscience, Inc. (NASDAQ: VIVO) anunciou hoje o lançamento do Mix HS de Pfu de Alta Especificidade que além de fornecer amplificação de alta...
Meridian Melancarkan Polimerase Fideliti Tinggi Baharu untuk Menawarkan Penguatan Kukuh untuk Aplikasi NGS dan PCR
January 23, 2020 16:46 ET
|
Meridian Bioscience Inc.
CINCINNATI, Jan. 24, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) hari ini mengumumkan Campuran HS Pfu Spesifikasi Tinggi yang bukan sahaja menyediakan penguatan fideliti...
Meridian Meluncurkan Polimerase Fidelitas Tinggi Baru dengan Kemampuan Amplifikasi Canggih bagi Aplikasi NGS dan PCR
January 23, 2020 16:46 ET
|
Meridian Bioscience Inc.
CINCINNATI, Jan. 24, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) hari ini mengumumkan peluncuran High-Specificity Pfu HS Mix yang menyediakan amplifikasi fidelitas tinggi,...
Meridian lance une nouvelle polymérase haute-fidélité pour fournir une amplification robuste aux applications NGS et PCR
January 23, 2020 16:46 ET
|
Meridian Bioscience Inc.
CINCINNATI, 23 janv. 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ : VIVO) a annoncé aujourd'hui le lancement d'un mélange Pfu HS de haute spécificité qui non seulement fournit une...